Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Cancer Education
Published in: Journal of Cancer Education 1/2013

01-03-2013

American Indian Perceptions of Colorectal Cancer Screening: Viewpoints from Adults Under Age 50

Authors: Melissa K. Filippi, Stacy Braiuca, Lance Cully, Aimee S. James, Won S. Choi, K. Allen Greiner, Christine M. Daley

Published in: Journal of Cancer Education | Issue 1/2013

Login to get access

Abstract

Colorectal cancer (CRC) mortality rates have decreased in the general US population; however, CRC mortality rates are increasing among American Indians (AI). AI CRC screening rates remain low when compared to other ethnic groups. Our team investigated CRC screening education prior to recommended age for screening to better understand screening perceptions among AI community members. Our research team conducted 11 focus groups with AI men and women aged 30–49 (N = 39 men and N = 31 women) in Kansas and Missouri. The results revealed that community members (1) have little knowledge of CRC, (2) do not openly discuss CRC, and (3) want additional CRC education. Variations existed among men and women's groups, but they agreed that preventive measures need to be appropriate for AI communities. Thus, AI CRC screening interventions should be culturally tailored to better meet the needs of the population.
Literature
1.
2.
Rim SH, Seeff L, Ahmed F, King JB, Coughlin SS (2009) Colorectal cancer incidence in the United States, 1999–2004: an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program. Cancer 115(9):1967–1976. doi:10.​1002/​cncr.​24216 PubMedCrossRef
3.
Espey D, Paisano R, Cobb N (2003) Cancer mortality among American Indians and Alaska Natives: regional differences, 1994–1998. Indian Health Service, Rockville, IHS Pub. No. 97-615-28
4.
Day GE, Provost E, Lanier AP (2009) Alaska native mortality rates and trends. Public Health Rep 124(1):54–64PubMed
5.
Lanier AP, Day GE, Kelly JJ, Provost E (2008) Disparities in cancer mortality among Alaska Native people, 1994–2003. Alaska Med 49(4):120–125PubMed
6.
Perdue DG, Perkins C, Jackson-Thompson J, Coughlin SS, Ahmed F, Haverkamp DS, Jim MA (2008) Regional differences in colorectal cancer incidence, stage, and subsite among American Indians and Alaska Natives, 1999–2004. Cancer 113(5 Suppl):1179–1190. doi:10.​1002/​cncr.​23726 PubMedCrossRef
7.
Frost F, Taylor V, Fries E (1992) Racial misclassification of Native Americans in a surveillance, epidemiology, and end results cancer registry. J Natl Cancer Inst 84(12):957–962PubMedCrossRef
8.
Ward E, Jemal A, Cokkinides V, Singh GK, Cardinez C, Ghafoor A, Thun M (2004) Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 54(2):78–93PubMedCrossRef
9.
10.
11.
Rosenberg T, Martel S (1998) Cancer trends from 1972–1991 for registered Indians living on Manitoba Reserves. Int J Circumpolar Health 57(Suppl 1):391–398PubMed
12.
Jim M (2007) Cancer in American Indians: data linkages. Southern Plains Inter-tribal Epidemiology Center, Oklahoma City Area Indian Health Board Report to the Tribes: cancer update. Southern Plains Inter-tribal Epidemiology Center, Oklahoma
13.
Yankaskas BC, Knight KL, Fleg A, Rao C (2009) Misclassification of American Indian race in state cancer data among non-federally recognized Indians in North Carolina. J Regist Manag 36(1):7–11
14.
Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, Woolf SH et al (1997) Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 112(2):594–642PubMedCrossRef
15.
Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328(19):1365–1371PubMedCrossRef
16.
Mandel JS, Church TR, Ederer F, Bond JH (1999) Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 91(5):434–437PubMedCrossRef
17.
Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, Snover DC, Schuman LM (2000) The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343(22):1603–1607PubMedCrossRef
18.
Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS (1992) A case–control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326(10):653–657PubMedCrossRef
19.
Atkin WS, Hart A, Edwards R, McIntyre P, Aubrey R, Wardle J, Sutton S, Cuzick J, Northover JM (1998) Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening. Gut 42(4):560–565PubMedCrossRef
20.
Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM (1992) Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 84(20):1572–1575PubMedCrossRef
21.
Winawer SJ, Zauber AG (2001) Colonoscopic polypectomy and the incidence of colorectal cancer. Gut 48(6):753–754PubMedCrossRef
22.
Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, Waye JD et al (1993) Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 329(27):1977–1981PubMedCrossRef
23.
Muller AD, Sonnenberg A (1995) Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case–control study of 32,702 veterans. Ann Intern Med 123(12):904–910PubMed
24.
Seeff LC, Shapiro JA, Nadel MR (2002) Are we doing enough to screen for colorectal cancer? Findings from the 1999 Behavioral Risk Factor Surveillance System. J Fam Pract 51(9):761–766PubMed
25.
Lemon S, Zapka J, Puleo E, Luckmann R, Chasan-Taber L (2001) Colorectal cancer screening participation: comparisons with mammography and prostate-specific antigen screening. Am J Public Health 91(8):1264–1272PubMedCrossRef
26.
From the Centers for Disease Control and Prevention (1997) Self-reported use of mammography among women aged > or =40 years—United States, 1989 and 1995. JAMA 278(17):1395–1396CrossRef
27.
Sirovich BE, Schwartz LM, Woloshin S (2003) Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? JAMA 289(11):1414–1420PubMedCrossRef
28.
Espey DK, Wu XC, Swan J, Wiggins C, Jim MA, Ward E, Wingo PA et al (2007) Annual report to the nation on the status of cancer, 1975–2004, featuring cancer in American Indians and Alaska Natives. Cancer 110(10):2119–2152. doi:10.​1002/​cncr.​23044 PubMedCrossRef
29.
30.
Day LW, Espey DK, Madden E, Segal M, Terdiman JP (2011) Screening prevalence and incidence of colorectal cancer among American Indian/Alaskan Natives in the Indian Health Service. Dig Dis Sci 56(7):2104–2113. doi:10.​1007/​s10620-010-1528-3 PubMedCrossRef
31.
Holm JE, Vogeltanz-Holm N, Poltavski D, McDonald L (2010) Assessing health status, behavioral risks, and health disparities in American Indians living on the northern plains of the U.S. Public Health Rep 125(1):68–78PubMed
32.
Steele CB, Cardinez CJ, Richardson LC, Tom-Orme L, Shaw KM (2008) Surveillance for health behaviors of American Indians and Alaska Natives—findings from the behavioral risk factor surveillance system, 2000–2006. Cancer 113(5 Suppl):1131–1141. doi:10.​1002/​cncr.​23727 PubMedCrossRef
33.
Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM (1996) Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348(9040):1472–1477PubMedCrossRef
34.
Guadagnolo BA, Cina K, Helbig P, Molloy K, Reiner M, Cook EF, Petereit D (2009) Assessing cancer stage and screening disparities among Native American cancer patients. Public Health Rep 124(1):79–89PubMed
35.
Bejes C, Marvel MK (1992) Attempting the improbable: offering colorectal cancer screening to all appropriate patients. Fam Pract Res J 12(1):83–90PubMed
36.
Myers RE, Ross EA, Wolf TA, Balshem A, Jepson C, Millner L (1991) Behavioral interventions to increase adherence in colorectal cancer screening. Med Care 29(10):1039–1050PubMedCrossRef
37.
Arveux P, Durand G, Milan C, Bedenne L, Levy D, Doan BD, Faivre J (1992) Views of a general population on mass screening for colorectal cancer: the Burgundy Study. Prev Med 21(5):574–581PubMedCrossRef
38.
Hunter W, Farmer A, Mant D, Verne J, Northover J, Fitzpatrick R (1991) The effect of self-administered faecal occult blood tests on compliance with screening for colorectal cancer: results of a survey of those invited. Fam Pract 8(4):367–372PubMedCrossRef
39.
Powe BD (1995) Fatalism among elderly African Americans. Effects on colorectal cancer screening. Cancer Nurs 18(5):385–392PubMedCrossRef
40.
Hoogewerf PE, Hislop TG, Morrison BJ, Burns SD, Sizto R (1990) Health belief and compliance with screening for fecal occult blood. Soc Sci Med 30(6):721–726PubMedCrossRef
41.
Vernon SW, Acquavella JF, Yarborough CM, Hughes JI, Thar WE (1990) Reasons for participation and nonparticipation in a colorectal cancer screening program for a cohort of high risk polypropylene workers. J Occup Med 32(1):46–51PubMedCrossRef
42.
Vernon SW, Gilstrap EL, Jackson GL, Hughes JI (1992) An intervention to increase participation in a work site cancer screening program. Health Values 16:3–9
43.
44.
James AS, Campbell MK, Hudson MA (2002) Perceived barriers and benefits to colon cancer screening among African Americans in North Carolina: how does perception relate to screening behavior? Cancer Epidemiol Biomark Prev 11(6):529–534
45.
46.
Klabunde CN, Vernon SW, Nadel MR, Breen N, Seeff LC, Brown ML (2005) Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adults. Med Care 43(9):939–944PubMedCrossRef
47.
Daley CM, James AS, Filippi M, Weir M, Braiuca S, Kaur B, Choi WS, Greiner KA (2012) American Indian community leader and provider views of needs and barriers to colorectal cancer screening. J Health Disparities Res Pract 5(2)
48.
Holmes-Rovner M, Williams GA, Hoppough S, Quillan L, Butler R, Given CW (2002) Colorectal cancer screening barriers in persons with low income. Cancer Pract 10(5):240–247PubMedCrossRef
49.
Lipkus IM, Rimer BK, Lyna PR, Pradhan AA, Conaway M, Woods-Powell CT (1996) Colorectal screening patterns and perceptions of risk among African-American users of a community health center. J Commun Health 21(6):409–427CrossRef
50.
O'Malley AS, Forrest CB, Mandelblatt J (2002) Adherence of low-income women to cancer screening recommendations: the roles of primary care health insurance, and HMOs. J Gen Intern Med 17:144–154PubMedCrossRef
51.
Schumacher MC, Slattery ML, Lanier AP, Ma KN, Edwards S, Ferucci ED, Tom-Orme L (2008) Prevalence and predictors of cancer screening among American Indian and Alaska native people: the EARTH study. Cancer Causes Control 19(7):725–737. doi:10.​1007/​s10552-008-9135-8 PubMedCrossRef
52.
53.
54.
Ellerbeck EF, Engelman KK, Gladden J, Mosier MC, Raju GS, Ahluwalia JS (2001) Direct observation of counseling on colorectal cancer in rural primary care practices. J Gen Intern Med 16(10):697–700PubMedCrossRef
55.
Daley CM, James AS, Ulrey E, Joseph S, Talawyma A, Choi WS, Greiner KA, Coe MK (2010) Using focus groups in community-based participatory research: challenges and resolutions. Qual Heal Res 20(5):697–706. doi:10.​1177/​1049732310361468​ CrossRef
Metadata
Title
American Indian Perceptions of Colorectal Cancer Screening: Viewpoints from Adults Under Age 50
Authors
Melissa K. Filippi
Stacy Braiuca
Lance Cully
Aimee S. James
Won S. Choi
K. Allen Greiner
Christine M. Daley
Publication date
01-03-2013
Publisher
Springer-Verlag
Published in
Journal of Cancer Education / Issue 1/2013
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-012-0428-y

Other articles of this Issue 1/2013

Journal of Cancer Education 1/2013 Go to the issue

OriginalPaper

The Eastland Prostate Cancer Survey: Instrument Development and Psychometric Testing

OriginalPaper

Skin Cancer Education among Massage Therapists: A Survey at the 2010 Meeting of the American Massage Therapy Association

OriginalPaper

Evaluation of a Method to Improve the Consent Process: Improved Data Retention with Stagnant Comprehension

OriginalPaper

The Impact of Undergraduate Education in Radiation Oncology

OriginalPaper

Improving Sun-Safe Knowledge, Attitude and Behaviour in Parents of Primary School Children: a Pilot Study

Reflection

Pumpkin Therapy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits